CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc.
CLEARWATER, FLORIDA, UNITED STATES, March 26, 2020 /EINPresswire.com/…
March 25, 2020/by michelle hallJanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development
FOR IMMEDIATE RELEASE
JanOne strikes agreement with CoreRx,…
February 4, 2020/by michelle hallJanOne strikes agreement with CoreRx,…
CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING PRODUCT DEVELOPMENT CAPACITY
CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING…
October 28, 2019/by Studio 98Biotech Stock On The Radar: Aimmune Awaits Adcom Test
September 12, 2019/by Studio 98CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment
Clearwater, Florida, May 14, 2019 — CoreRx, Inc. today announced
that…
May 13, 2019/by michelle hallthat…
CORERX, INC. ADDS INCREASING PRODUCT DEVELOPMENT CAPACITY Company to Continue Investments, Increase Workforce
March 17, 2019/by michelle hallLocation
14205 Myerlake Circle
Clearwater, FL 33760 USA
Contact Us
Phone: 727.259.6950
Toll Free: 877.461.4448
Fax: 727.683.9530